26816916|t|Valproate Induced Hyperammonemic Delirium.
26816916|a|Sodium valproate induced hyperammonaemic delirium with normal liver function tests is a relatively uncommon adverse effect. It may be mistaken for psychosis or worsening of mania leading to wrong diagnosis and improper management. Plasma ammonia levels should be monitored in all patients developing altered mental status after receiving valproate therapy. This is a case series of hyperammonaemic delirium due to valproate reported to the Department of Pharmacology from Department of Psychiatry over a period of one year. 
26816916	0	9	Valproate	Chemical	MESH:D014635
26816916	18	41	Hyperammonemic Delirium	Disease	MESH:D003693
26816916	43	59	Sodium valproate	Chemical	MESH:D014635
26816916	68	92	hyperammonaemic delirium	Disease	MESH:D003693
26816916	190	199	psychosis	Disease	MESH:D011618
26816916	216	221	mania	Disease	MESH:D001714
26816916	281	288	ammonia	Chemical	MESH:D000641
26816916	323	331	patients	Species	9606
26816916	343	364	altered mental status	Disease	MESH:D013226
26816916	381	390	valproate	Chemical	MESH:D014635
26816916	425	449	hyperammonaemic delirium	Disease	MESH:D003693
26816916	457	466	valproate	Chemical	MESH:D014635
26816916	Association	MESH:D014635	MESH:D001714
26816916	Positive_Correlation	MESH:D014635	MESH:D003693
26816916	Association	MESH:D014635	MESH:D013226
26816916	Association	MESH:D000641	MESH:D013226
26816916	Association	MESH:D000641	MESH:D014635

